Repligen

Repligen

Repligen | Inspiring Advances in Bioprocessing.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
*
N/A

$600m

Post IPO Convertible
Total Funding000k
No items found
No investors found

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
USD2021202220232024202520262027
Revenues0000000000000000000000000000
% growth83 %20 %(20 %)(1 %)12 %14 %17 %
EBITDA0000000000000000000000000000
% EBITDA margin26 %23 %14 %8 %19 %22 %24 %
Profit0000000000000000000000000000
% profit margin19 %23 %7 %(4 %)6 %9 %12 %
EV0000000000000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000
R&D % of revenue5 %5 %7 %7 %---

Source: Company filings or news article, Equity research estimates

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by Repligen

Edit
Tantti Laboratory
ACQUISITION by Repligen Jul 2024
TangenX Technology Corp
ACQUISITION by Repligen Dec 2016
Spectrum Laboratories
ACQUISITION by Repligen Jun 2017
Atoll GmbH
ACQUISITION by Repligen Apr 2016
Avitide
ACQUISITION by Repligen Sep 2021
Artesyn Biosolutions
ACQUISITION by Repligen Nov 2020
Metenova
ACQUISITION by Repligen Sep 2023
Polymem
ACQUISITION by Repligen Jun 2021